What it is
Semax is a synthetic heptapeptide derived from a fragment of the natural hormone ACTH (adrenocorticotropic hormone), specifically the 4–10 region, with an added Pro-Gly-Pro 'tail' that makes it more stable and strips out the hormonal (adrenal-stimulating) activity of the parent molecule. What's left is intended to act on the brain rather than the stress-hormone system.
It was developed in Russia in the late 1980s–1990s and has been registered there as a pharmaceutical drug (typically a nasal spray) since the mid-1990s, used for conditions like ischemic stroke recovery, cognitive impairment, and optic nerve disorders.
In the United States and most of the West it is neither approved nor a recognized medicine. It is sold only as a 'for laboratory research use only' chemical, not as a supplement or drug for human use.
How it works
Semax's best-documented action is boosting neurotrophic factors — the brain's own 'growth and repair' proteins, especially BDNF (brain-derived neurotrophic factor) and its receptor TrkB, along with NGF (nerve growth factor). In rat studies, a single dose increased BDNF protein and gene expression in the hippocampus (a memory hub) within about 90 minutes, with effects lasting up to 24 hours. Because BDNF supports the survival, growth, and connectivity of neurons, this is the leading explanation for its claimed pro-cognitive and neuroprotective effects.
Semax is also reported to modulate brain neurotransmitter systems — including dopamine and serotonin pathways — and to influence genes involved in inflammation and blood-vessel biology after simulated strokes in animals. In plain terms: the peptide appears to nudge the brain toward a more resilient, plastic, less-inflamed state. Much of this detailed mechanism work is in animals, so how completely it translates to humans is not fully established.
What people research it for
Stroke recovery support
Early human dataRussian clinical studies in ischemic stroke patients reported faster functional recovery, better motor performance, and rising plasma BDNF when Semax was added to rehabilitation.
Cognition, focus, and learning
Animal studiesReported and studied as a nootropic for attention and memory; animal work links it to improved learning tasks via BDNF/TrkB signaling. Human cognitive-enhancement data in healthy people is thin.
Neuroprotection
Preclinical / theorizedIn rat models of cerebral ischemia, Semax reduced neuronal damage and shifted gene expression toward protective, anti-inflammatory pathways.
Mood and stress resilience
Preclinical / theorizedAnecdotally and in some early reports, users describe reduced anxiety and steadier mood, plausibly tied to dopamine/serotonin modulation, but controlled human evidence is limited.
What the research actually shows
The bulk of Semax's human evidence comes from Russia, where it has been used clinically for decades. Randomized and controlled Russian trials — for example in ischemic stroke — report faster recovery and improved outcomes (e.g., Barthel index) alongside increased plasma BDNF, and these studies are indexed on PubMed.
The honest caveat is geographic and methodological: almost all of this work was conducted, published, and reviewed within the Russian medical system. There is very little independent replication by Western research groups, few large modern placebo-controlled trials meeting current FDA/EMA standards, and limited published safety surveillance outside Russia.
So the picture is genuinely mixed: this is not a purely 'unstudied' compound — there is real human data — but that data sits in an evidence bubble that Western regulators and reviewers have not validated. Treat strong human-benefit claims with appropriate caution.
Research handling & storage
In its Russian medical form and in research use, Semax is most often delivered intranasally (as drops or spray), which sends it toward the brain while bypassing the digestive tract. Research-grade material is typically supplied as a lyophilized (freeze-dried) white powder that must be reconstituted before use, commonly with bacteriostatic or sterile water added slowly down the vial wall and gently swirled — never shaken — until dissolved.
Lyophilized powder is generally most stable frozen (around -20°C, up to ~24 months) and can be kept refrigerated for shorter periods; once reconstituted it should be refrigerated (2–8°C), protected from light, and used within a few weeks. N-acetylated variants (NA-Semax, NA-Semax Amidate) are engineered for greater stability and a longer half-life. This is research-handling context only, not a human-use protocol.
Safety & cautions
In Russian clinical use and user reports, Semax is often described as well tolerated, with the most commonly noted effect being transient mild nasal irritation or tingling after intranasal dosing. Its design deliberately removed the hormonal activity of parent ACTH, which is part of why it isn't expected to act like a steroid.
That said, long-term safety data — especially outside Russia and for the newer N-acetyl variants — is limited, and independent Western safety monitoring is essentially absent. Some sources flag possible effects on blood pressure with certain variants. Because Semax is unapproved in the West and sold for research only, purity, dosing, and quality are unregulated, and there is no Western medical oversight; it should not be self-administered as a treatment.
Track Semax prices
Get an alert when a trusted, tested vendor drops the price. Free.
Frequently asked questions
Is Semax FDA approved?
No. Semax has no FDA approval and is not a recognized medicine or supplement in the United States. In the West it is sold only as a 'for laboratory research use only' chemical.
Why is it only approved in Russia?
Semax was developed in Russia and cleared through the Russian pharmaceutical system, where it's been a registered drug since the mid-1990s. Western regulators like the FDA require their own large, standardized clinical trials, and those haven't been done — so approval never crossed over.
Is the Russian human evidence trustworthy?
There is genuine human data, including controlled stroke trials indexed on PubMed. The limitation is that it's largely unreplicated outside Russia and doesn't meet modern Western trial standards, so it should be read as promising but not independently confirmed.
What's the difference between Semax and N-Acetyl Semax Amidate?
N-Acetyl Semax Amidate (NASA) is a chemically modified version designed to be more stable and longer-acting than standard Semax. It has even less formal clinical study than the original.
How is it typically taken in research contexts?
Most commonly intranasally, from reconstituted freeze-dried powder. We don't provide human dosing — Semax is unapproved in the West and framed here only as research context.
Sources
- Semax regulates BDNF/trkB in rat hippocampus — Brain Research, 2006 (PubMed)
- Efficacy of semax in ischemic stroke patients — Zh Nevrol Psikhiatr, 2018 (PubMed)
- Semax, an ACTH(4-10) analogue with nootropic properties (PubMed)
- Semax — Cognitive Vitality for Researchers (Alzheimer's Drug Discovery Foundation)
Last reviewed 2026-07-07. This guide is educational and research-focused — not medical advice. Semax products referenced on PeptidePub are sold by third parties as materials for laboratory research use only, not for human or animal consumption.
Related peptides
Ready to compare Semax?
See prices across trusted, third-party-tested vendors, normalized per milligram.
Compare Semax prices →